mencer-mike-headshot

GET IN TOUCH

See what Worldwide Clinical Trials can do for you.

Mike Mencer

Executive Vice President and General Manager, Early Phase

Mike Mencer is currently EVP and General Manager, Early Phase Services for Worldwide Clinical Trials. Previously, he was the Executive Director of Business Development Operations for Advanced Enrollment Solutions, a subsidiary of PPD, a leading global CRO providing advanced clinical patient enrollment services. There he was leading and transforming the Inside Sales and Sales Operations teams. He was also the Managing Director of DMM Triangle Services, LLC, a consulting firm engaged in assisting small and start-up companies to integrate business strategy with CMC operations; establish operational excellence practices, optimize Business Development operations as well as provide general management consulting.

In addition, he was the Vice President of Pharmaceutical Development Operations for Patheon N.V., a leading global pharmaceutical Contract Development and Manufacturing Organization and part of Thermo Fisher Scientific (NYSE: TMO). Patheon N.V. was formed in March 2014 through the $2.6B merger of Canadian drug maker Patheon Inc. and the drug business of Dutch conglomerate Royal DSM. Patheon held its Initial NYSE Public Offering in July of 2016 and was purchased by Thermo Fisher Scientific in 2017. As VP, he served as regional general manager and P&L owner for the North American development sites in North Carolina, Ohio, and Oregon. Additionally, Mike led Patheon’s initiative to establish a global, vertically integrated offering by combining drug substance and drug product development and manufacturing into a single customized solution. During his tenure with Patheon, he led sites and teams in France, Italy, Netherlands, UK and US and was a key senior change management leader for five significant M&A integrations.

Prior to joining Patheon in 2003, he held roles of increasing responsibility for companies that are now part of Teva Pharmaceutical Industries (NYSE: TEVA) and Sanofi S.A. (NASDAQ: SNY) as well as teaching graduate level project management courses for The University of Cincinnati, Division of Pharmaceutical Sciences as an adjunct professor.

He received his BS in Chemical Sciences from Xavier University, maintains a PMP certification, has participated in leadership development study at the Center of Creative Leadership and received his operational excellence training from McKinsey & Company.